stella
beta
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab — Stella
Recruiting
Back to Hidradenitis Suppurativa trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
United States
Physioseq, LLC /ID# 267266, Sacramento, California
University of Michigan Health System - Ann Arbor /ID# 267275, Ann Arbor, Michigan
View full record on ClinicalTrials.gov